Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Importance of Baseline Fluorescein Angiography for Patients Presenting to Tertiary Uveitis Clinic.
Karaca I, Bromeo A, Ghoraba H, Lyu X, Thng ZX, Yasar C, Akhavanrezayat A, Yavari N, Kirimli GU, Than NTT, Shin Y, Gupta AS, Khatri A, Mohammadi SS, Hung JH, Or C, Do DV, Nguyen QD. Karaca I, et al. Among authors: do dv. Am J Ophthalmol. 2024 May 1:S0002-9394(24)00170-3. doi: 10.1016/j.ajo.2024.04.016. Online ahead of print. Am J Ophthalmol. 2024. PMID: 38701875
Risk factors for development of anti-adalimumab antibodies in non-infectious uveitis.
Bromeo AJ, Karaca I, Ghoraba HH, Lyu X, Than NTT, Ongpalakorn P, Shin YU, Uludag G, Tran ANT, Thng ZX, Do DV, Or CMC, Nguyen QD. Bromeo AJ, et al. Among authors: do dv. Heliyon. 2024 Apr 5;10(9):e29313. doi: 10.1016/j.heliyon.2024.e29313. eCollection 2024 May 15. Heliyon. 2024. PMID: 38694084 Free PMC article.
Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review.
Bressler NM, Kaiser PK, Do DV, Nguyen QD, Park KH, Woo SJ, Sagong M, Bradvica M, Kim MY, Kim S, Sadda SR. Bressler NM, et al. Among authors: do dv. Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00029-8. doi: 10.1016/j.survophthal.2024.03.009. Online ahead of print. Surv Ophthalmol. 2024. PMID: 38521423 Free article. Review.
Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.
Karaca I, Tran EM, Park S, Bromeo A, Khojasteh H, Tran ANT, Yavari N, Akhavanrezayat A, Yasar C, Uludag Kirimli G, Than NTT, Hassan M, Or C, Ghoraba H, Do DV, Nguyen QD. Karaca I, et al. Among authors: do dv. J Ophthalmic Inflamm Infect. 2024 Mar 11;14(1):12. doi: 10.1186/s12348-023-00372-z. J Ophthalmic Inflamm Infect. 2024. PMID: 38466527 Free PMC article.
290 results